Japan, Sept. 16 -- SHENZHEN NEW INDUSTRY BIOMEDICAL ENGINEERING CO has got intellectual property rights for 'METHOD OF DETECTING TARGETED IMMUNOSUPPRESSANT IN WHOLE BLOOD WITHOUT CENTRIFUGATION BY COMBINATION OF REAGENTS.' Other related details are as follows:
Application Number: JP,2024-231006
Category (FI): A61P37/06,G01N33/543,541@A,G01N33/53@S,G01N33/536@D
Stage: PROBLEM TO BE SOLVED: To provide a combination of reagents that is low in toxicity and safe, and a method of detecting targeted immunosuppressants in whole blood.SOLUTION: The present invention relates to the field of in vitro detection technology, specifically to a method of detecting targeted immunosuppressants in whole blood without centrifugation by a combination of reagents. The present invention is to provide a safe combination of reagents with low toxicity and a method of detecting targeted immunosuppressants in whole blood; the method according to the present invention can be used for performing immunodetection, and the detection results can be highly consistent with mass spectrometry analytical detection results, which shows that the whole blood treatment agent of the present invention can be used for treating a specimen, and bound medicines can be fully released, and the obtained medicines in free state can meet the requirements of immunodetection. The detection method provided by the present invention truly realizes detection without centrifugation and greatly improves detection efficiency.SELECTED DRAWING: None (Grant)
Filing Date: Dec. 26, 2024
Publication Date: July 11, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
